Moreover, the new drug can be used to diagnose breast, pharyngeal and laryngeal cancer
TOMSK, December 7. /TASS/. Scientists at Tomsk Polytechnic University became the first in Russia to start producing and supplying to the Research Institute of Cardiology a radiopharmaceutical based on thallium-199 isotope, which allows to quickly and accurately diagnose heart pathologies, in particular, ischemic disease. In contrast to the thallium-201 drug used for these purposes, it is easier for the patient to tolerate, has less radiation exposure and is quickly eliminated from the body, the press service of the Tomsk university told reporters.
“Both in the world and in Russia, a drug with thallium-201 isotope is traditionally used for diagnostics in cardiology. Tomsk Polytechnic University has developed its own technology for obtaining thallium-199. Its half-life amounts to 7.4 hours, which is almost ten times less than thallium-201. This means that it is softer , gives less dose to the